MedPath

Intervention study on the effect of vitamin K2 (Menaquinone-7) supplementation on the vascular stiffness in subjects with poor vitamin K-status.

Recruiting
Conditions
vascular stiffness
vitamin K deficiency
10003216
Registration Number
NL-OMON47354
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
243
Inclusion Criteria

Men and women between 40 and 70 years of age
Subjects having a BMI between 20 and 35 kg/m2
Subjects of the Caucasian race
Subjects having circulating values of dp-ucMGP higher than 400 pmol/L
Subjects given written consent to take part in the study

Exclusion Criteria

Subjects with hyperlipedaemia
Subjects with cardiovascular disease
Women treated with estrogens
Subjects on oral anticoagulant therapy
Subjects with (a history of) metabolic or gastrointestinal disease
Subjects taking vitamin K containing (multi)vitamin supplements

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study parameters of this study is to investigate the effects of<br /><br>MK-7 supplementation on vascular characteristics. The main study parameters are<br /><br>the percentage of changes in the clinical end points: pulse-wave velocity,<br /><br>carotid elasticity and intima-media thickness after one year of treatment<br /><br>between the two treatment groups (placebo and MK-7).<br /><br><br /><br>Primary study parameter of the follow-up study is to investigate the<br /><br>correlation between the 3 different non-invasive measurements for vascular<br /><br>stiffness among healthy subjects.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study parameter is the relative changes in the biochemical<br /><br>parameters i.e. dp-ucMGP fraction after one year of treatment. </p><br>
© Copyright 2025. All Rights Reserved by MedPath